Trastuzumab Does Not Benefit HER2-Low Breast Cancer Patients

Trastuzumab Does Not Benefit HER2-Low Breast Cancer Patients

Cutler is hopeful that neratinib, which was approved in the extended adjuvant setting in breast cancer in July, can provide clinical benefit to the rare liver cancer patient population and, in this video, he explains why.

MONALEESA-7 investigated efficacy and safety of Kisqali in combination with tamoxifen or non-steroidal aromatase inhibitor plus goserelin in premenopausal or perimenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+HER2-) advanced breast cancer.

Hershman's team wondered if the ancient practice of acupuncture might help.

Novartis is looking for an expanded combination therapy label for its Kisqali after a trial showed it halts progression of an aggressive kind of breast cancer in younger women for longer than standard drugs.

"This is yet another study that reveals the benefits of acupuncture in treating pain", Coomer said. The BPI is a self-administered 14-item questionnaire created to assess pain on a scale from zero to 10, where higher scores indicate more pain. The patients were monitored for another 12 weeks after stopping acupuncture treatments, and reported on their pain using various methods, including the BPI, throughout this 24-week period.

"If something so simple as acupuncture can improve upon these symptoms and the patients' quality of life, we will have more women becoming compliant in taking their medication, and one would expect improved outcomes", Cassell added. Of the patients in the study, 110 received true acupuncture, 59 were given fake acupuncture - needles placed at ineffective spots on the body - and another 57 were placed on a waiting list.

For more from Rare Disease Report, follow along on Facebook and Twitter.

The study had a median follow-up of 46.1 months, during which time 264 patients had a recurrence, diagnosis of a new breast cancer, diagnosis of a new cancer outside the breast, or died. "We need to identify strategies to control these side effects, the most common of which is debilitating joint pain and stiffness".

Breastcancer.org has more on aromatase inhibitors. "We have a huge problem in this country with pain medications, and it's imperative to find alternative ways of controlling pain and discomfort so that individuals with breast cancer can stay on their treatment".

Related:

Comments

Latest news

Border protection grid to be set up in Border States: Rajnath Singh
Banerjee has been very vocal on the Centre's decision to withdraw central forces from Darjeeling during serious unrest following the demand of Gorkhaland by Bimal Gurung and his associates.

B-1B, F-22 jets hold attack drills in Korea
White House national security adviser HR McMaster stated that the chances for war on the Korean Peninsula grow daily. According to reports , the US 7th Air Force deployed six F-22 and 18 F-35 stealth fighter jets for the exercise.

Analysts Weigh in on Walter Investment Management Corp (WAC)
Market worth or Market capitalization is calculated by multiplying the price of a stock by its total number of outstanding shares. The sales growth rate for a stock is a measure of how the stock's sales per share (SPS) has grown over a specific period of time.

CarMax (NYSE:KMX): What Moffett Nathanson Is Saying About Their Stock
CarMax is the nation's largest retailer of used cars and operates more than 185 stores in 39 states nationwide. The company reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.95 by $0.03.

Flagship Harbor Advisors LLC Grows Position in Schlumberger Limited. (SLB)
The oil and gas company reported $0.42 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.42. The firm has a market capitalization of $85,860.00, a price-to-earnings ratio of 49.19, a PEG ratio of 1.94 and a beta of 1.01.

Other news